USE OF TISSUE FACTOR AGONIST OR TISSUE FACTOR ANTAGONIST FOR TREATMENT OF CONDITIONS RELATED TO APOPTOSIS
摘要
<p>The present invention relates to use of FVII and/or FVIIa and/or another TF agonist and/or FVIIai and/or another TF antagonist in therapeutic treatment of pathological conditions increased or decreased cell apoptosis is required.</p>
